Table 8.
Age |
≥75 Yrs |
70–74 Yrs |
||||
---|---|---|---|---|---|---|
Copayment proportion | 30% | 10% | P Value | 30% | 20% | P Value |
Newly treated AMD patients | 10 463 | 104 717 | - | 4947 | 37 633 | - |
Anti-VEGF injection numbers in the first 1 yr (mean ± SD) | 3.94 ± 2.37 | 3.74 ± 2.29 | <0.0001 | 3.98 ± 2.37 | 3.83 ± 2.35 | 0.0003 |
Anti-VEGF Injection Numbers in 3 yrs (mean ± SD) | 6.95 ± 5.95 | 6.37 ± 5.64 | <0.0001 | 7.45 ± 6.40 | 6.94 ± 5.98 | 0.0003 |
AMD = age-related macular degeneration; SD = standard deviation; VEGF = vascular endothelial growth factor.
The basic copayment is 30%. If the annual income is <33 700 000 Japanese Yen, copayment is reduced to 10% and 20% for individuals aged ≥75 and 70–74 years, respectively.